READY FOR ITS CLOSEUP: A shipment of vials of remdesivir intended for clinical trial use. Gilead Sciences invested millions of dollars of independent research and development funding to…
Read More
BRIEFING THE BOSS: Secretary of Defense Mark T. Esper speaks with biological safety officer David Harbourt during a tour of USAMRIID at Fort Detrick in March. (Photo by John W….
